HEALTHY VOLUNTEERS NEEDED-C3941001

Study Graphic

You may be eligible if:

  • You are a healthy male or female (unable to bear children) 18-55 years of age.
  • You are able to meet all eligibility criteria.
  • You are able to comply with all study visits.

Study Number: C3941001

Be compensated for your time: up to $2400.00 for Part A or $3400.00 for Part B for completion of the study.

 The Pfizer New Haven Clinical Research Unit is conducting a study of a new investigational drug being studied to treat people with atopic dermatitis (AD). AD is a form of eczema (itchy, inflamed skin rash). This research study will be the first time the study drug will be applied to people. The study drug is an ointment that will be applied to the skin. The dose of the study drug to be used to treat people has not yet been determined. The dose strength of study drug will range from 0.01% to 0.06%.

This study involves:

You will be in this study up to about 39 days (Part A) or 42 days (Part B). This does not include the time between screening and dosing, which can be up to 28 days.

 This study involves:

Part A

  • 1 dosing period
  • 8 overnight stays
  • 1 follow-up phone call (about 28 to 31 days after the last dose of study drug)

Part B

  • 1 dosing period
  • 12 overnight stays
  • 1 follow-up phone call (about 28 to 31 days after the last dose of study drug)

Please review the informed consent document: C3941001_10-10-19 IC –

Please review more information about the study: C3941001 final Guidelines-Restrictions-Dates v24Oct2019_1